Ayoubi T A, Meulemans S M, Roebroek A J, Van de Ven W J
Laboratory for Molecular Oncology, University of Leuven, Belgium.
Mol Biol Rep. 1996;23(2):87-95. doi: 10.1007/BF00424434.
The proprotein processing enzyme furin is the mammalian prototype of a novel family of subtilisin-like serine endoproteases which possess cleavage specificity for sites involving multiple basic amino acid residues and are involved in the processing of precursor proteins of a variety of regulatory peptides and proteins. One of the limiting steps in the engineering of mammalian cells designed for the overproduction of secreted proteins is the endoproteolytic cleavage of the precursor molecule to its mature biologically active form. The extremely low level of endogenous furin is likely the reason why cells are not able to fully mature overexpressed precursor proteins to their mature form. Here, we report a CHO-derived cell line genetically engineered for the production of high levels of recombinant proteins that need such endoproteolytic maturation. First, the human furin cDNA under the control of the cytomegalovirus early promoter and enhancer was introduced and overexpressed in a DHFR-deficient CHO cell line. A permanent cell line CHO-D3-FUR was established that expressed biologically active furin. Subsequently, to demonstrate the capacity of CHO-D3-FUR cells to produce recombinant proteins in a fully matured form, two derivative cell lines were established that overexpressed the von Willebrand factor (vWF) and transforming growth factor beta 1 (TGF beta 1); CHO-D3-vWF and CHO-D3-TGF beta 1, respectively. Both derivative cell lines were able to produce relatively high levels of recombinant protein in a fully matured and biologically active form. Our results illustrate the potential of the CHO-D3-FUR cell line in the production of recombinant secretory proteins that need endoproteolytic activation at the consensus furin cleavage sequence Arg-X-Lys/Arg-Arg.
前蛋白加工酶弗林蛋白酶是枯草杆菌蛋白酶样丝氨酸内切蛋白酶新家族的哺乳动物原型,该家族对涉及多个碱性氨基酸残基的位点具有切割特异性,并参与多种调节肽和蛋白质前体蛋白的加工。在设计用于过量生产分泌蛋白的哺乳动物细胞工程中,一个限制步骤是前体分子内蛋白水解切割成其成熟的生物活性形式。内源性弗林蛋白酶水平极低可能是细胞无法将过表达的前体蛋白完全成熟为其成熟形式的原因。在此,我们报告了一种经基因工程改造的CHO衍生细胞系,用于生产需要这种内蛋白水解成熟的高水平重组蛋白。首先,将受巨细胞病毒早期启动子和增强子控制的人弗林蛋白酶cDNA导入并在缺乏二氢叶酸还原酶(DHFR)的CHO细胞系中过表达。建立了表达生物活性弗林蛋白酶的永久细胞系CHO-D3-FUR。随后,为了证明CHO-D3-FUR细胞以完全成熟形式生产重组蛋白的能力,建立了两个分别过表达血管性血友病因子(vWF)和转化生长因子β1(TGFβ1)的衍生细胞系;分别为CHO-D3-vWF和CHO-D3-TGFβ1。两个衍生细胞系都能够以完全成熟和生物活性形式产生相对高水平的重组蛋白。我们的结果说明了CHO-D3-FUR细胞系在生产需要在弗林蛋白酶切割序列共识位点Arg-X-Lys/Arg-Arg进行内蛋白水解激活的重组分泌蛋白方面的潜力。